Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advanced Cell Therapies for Glioblastoma. | Front Immunol | 2022 | 36052072 | PubTator, text mining | PubMed |
| Paving the road to make chimeric antigen receptor-T-cell therapy effective against solid tumors. | Cancer Sci | 2022 | 36047968 | PubTator, text mining | PubMed |
| Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies. | Front Immunol | 2022 | 36045670 | PubTator, text mining | PubMed |
| Reactive sulfur species and their significance in health and disease. | Biosci Rep | 2022 | 36039860 | PubTator, text mining | PubMed |
| Novel genetic associations with five aesthetic facial traits: A genome-wide association study in the Chinese population. | Front Genet | 2022 | 36035146 | PubTator, text mining | PubMed |
| Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review. | Cureus | 2022 | 36035049 | PubTator, text mining | PubMed |
| Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo. | Evid Based Complement Alternat Med | 2022 | 36034960 | PubTator, text mining | PubMed |
| A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36034466 | PubTator, text mining | PubMed |
| Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin's lymphoma. | Front Oncol | 2022 | 36033519 | PubTator, text mining | PubMed |
| Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib. | Gynecol Oncol Rep | 2022 | 36032811 | PubTator, text mining | PubMed |
| Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges. | Front Immunol | 2022 | 36032080 | PubTator, text mining | PubMed |
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. | J Hematol Oncol | 2022 | 36031601 | PubTator, text mining | PubMed |
| An integrative analysis to reveal that CLEC2B and ferroptosis may bridge the gap between psoriatic arthritis and cancer development. | Sci Rep | 2022 | 36030279 | PubTator, text mining | PubMed |
| Computational analysis of 4-1BB-induced NFκB signaling suggests improvements to CAR cell design. | Cell Commun Signal | 2022 | 36028884 | PubTator, text mining | PubMed |
| The pathophyiological role of aminoacyl-tRNA synthetases in digestive system diseases. | Front Physiol | 2022 | 36017335 | PubTator, text mining | PubMed |
| Road testing new CAR design strategies in multiple myeloma. | Front Immunol | 2022 | 36016950 | PubTator, text mining | PubMed |
| The Cellular and Molecular Immunotherapy in Prostate Cancer. | Vaccines (Basel) | 2022 | 36016257 | PubTator, text mining | PubMed |
| Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects. | Vaccines (Basel) | 2022 | 36016159 | PubTator, text mining | PubMed |
| Recent Advances and Challenges in Cancer Immunotherapy. | Cancers (Basel) | 2022 | 36010965 | PubTator, text mining | PubMed |
| Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma. | Curr Oncol | 2022 | 36005167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=58